BioNTech says it plans to develop an mRNA vaccine to prevent malaria - CNBC

German drugmaker BioNTech announced Monday it plans to develop an mRNA-based vaccine to prevent malaria, a life-threatening disease that impacts millions of people worldwide each year.

Israel says Pfizer Covid vaccine is just 39% effective, but still prevents severe illness?

"Together with our partners, we will do whatever it takes to develop a safe and effective mRNA-based Malaria vaccine that will prevent the disease, reduce mortality and ensure a sustainable solution for the African continent and other regions affected by this disease," he said.

The development of the new vaccine comes as world continues to deal with the Covid pandemic, which began spreading worldwide in early 2020 and has since killed more than 4.1 million people, according to data from Johns Hopkins University.

Pfizer and BioNTech quickly developed a highly effective mRNA-based vaccine to target the virus.

The mRNA-based Covid vaccine works by tricking the body to produce a harmless piece of the virus, triggering an immune response